VEGF INHIBITS HUMAN PROSTATE CANCER (HPC) GROWTH AND POTENTIATES ANTI-ANGIOGENESIS THERAPY
Mitchell H. Sokoloff(University of Virginia), Leland W.K. Chung(VA Palo Alto Health Care System), Jonathan W. Simons(Unknown), Michael J. Bradley, Haiyen E. Zhau(Cedars-Sinai Medical Center)
Cited by 3
Related Papers
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
|PubMed|1994|739
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
|JNCI Journal of the National Cancer Institute|2001|593
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
|Nature Protocols|2007|520